Agios Pharmaceuticals Inc. (AGIO) Moves 3.15% Higher: These Numbers are Too Good to be True

As on April 15, 2021, Agios Pharmaceuticals Inc. (NASDAQ: AGIO) got off with the flyer as it spiked 3.15% to $55.04. During the day, the stock rose to $55.77 and sunk to $53.665 before settling in for the price of $53.36 at the close. Taking a more long-term approach, AGIO posted a 52-week range of $32.47-$58.93.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

It was noted that the giant of the Healthcare sector posted annual sales growth of 28.00% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -8.60%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 30.80%. This publicly-traded company’s shares outstanding now amounts to $69.27 million, simultaneously with a float of $61.51 million. The organization now has a market capitalization sitting at $3.84 billion. At the time of writing, stock’s 50-day Moving Average stood at $51.48, while the 200-day Moving Average is $44.71.

It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 562 workers. It has generated 361,559 per worker during the last fiscal year. Meanwhile, its income per employee was -582,509. The stock had 9.98 Receivables turnover and 0.23 Total Asset turnover. For the Profitability, stocks gross margin was +89.29, operating margin was -155.59 and Pretax Margin of -161.11.

Agios Pharmaceuticals Inc. (AGIO) Ownership Facts and Figures

Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Agios Pharmaceuticals Inc.’s current insider ownership accounts for 0.30%, in contrast to 94.90% institutional ownership. According to the most recent insider trade that took place on Mar 05, this organization’s Chief Commercial Officer sold 500 shares at the rate of 48.58, making the entire transaction reach 24,290 in total value, affecting insider ownership by 10,671. Preceding that transaction, on Mar 01, Company’s Chief Commercial Officer sold 2,200 for 47.99, making the whole transaction’s value amount to 105,578. This particular insider is now the holder of 11,171 in total.

Agios Pharmaceuticals Inc. (AGIO) Earnings and Revenue Records

If we go through the results of last quarter, which was made public on 12/30/2020, the company posted -$1.41 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$1.33) by -$0.08. This company achieved a net margin of -161.11 while generating a return on equity of -62.95. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.57 per share during the current fiscal year.

Agios Pharmaceuticals Inc.’s EPS increase for this current 12-month fiscal period is 30.80% and is forecasted to reach -6.11 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 40.00% through the next 5 years, which can be compared against the -8.60% growth it accomplished over the previous five years trading on the market.

Agios Pharmaceuticals Inc. (NASDAQ: AGIO) Trading Performance Indicators

Let’s observe the current performance indicators for Agios Pharmaceuticals Inc. (AGIO). It’s Quick Ratio in the last reported quarter now stands at 6.60. The Stock has managed to achieve an average true range (ATR) of 2.56. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 18.91.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!


In the same vein, AGIO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.74, a figure that is expected to reach -1.34 in the next quarter, and analysts are predicting that it will be -6.11 at the market close of one year from today.

Technical Analysis of Agios Pharmaceuticals Inc. (AGIO)

Through scrutinizing the latest numbers posted by the [Agios Pharmaceuticals Inc., AGIO], it can be observed that its last 5-days Average volume of 0.72 million was lower the volume of 0.78 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 62.26% While, its Average True Range was 2.40.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Raw Stochastic average of Agios Pharmaceuticals Inc. (AGIO) in the period of the previous 100 days is set at 85.30%, which indicates a major fall in contrast to 92.23% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 38.16% that was lower than 70.11% volatility it exhibited in the past 100-days period.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

We do not sell or share your information with anyone.